Jump to a section
Start here (30 seconds)
A clinical trial listing is a public summary of a research study — who they're looking for, what they're testing, and whether it's still open.
You do not need to understand every word. Focus on three things: Is it recruiting? Does my child fit the eligibility? Is it studying something relevant to us?
Where to find trials
Trial phases — what they mean
Phase tells you how far along the research is — not whether it's right for your child.
- Phase 1 — First in humans. Main goal: is it safe? What dose is tolerable? Usually very small groups. Often not the right entry point for children unless specifically designed for pediatrics.
- Phase 2 — Does it seem to work? Still relatively small. Researchers watch for side effects and early signs of benefit.
- Phase 3 — Larger studies comparing to standard treatment or placebo. This is often the last step before seeking approval.
- Phase 4 — After approval. Long-term safety monitoring in the real world.
For rare diseases: trials may be smaller, combine phases, or use adaptive designs. A "Phase 1/2" study is common — don't let the label alone scare you off or convince you.
How to read a listing — section by section
Title & official name
Often technical. Search using your child's diagnosis, gene name, or treatment type rather than trying to decode the title.
Status
Look for Recruiting or Enrolling by invitation. "Active, not recruiting" means the study is running but not accepting new patients. "Completed" or "Terminated" — move on unless you're reading for background.
Eligibility (inclusion / exclusion criteria)
This is the gate. Read every line. Common filters: age range, specific mutation, prior treatments, organ function, ability to travel to study sites.
Locations
Where you'd actually go. A trial can be "open" nationally but only at three hospitals — check if one is reachable for your family.
Primary outcome
What the study is mainly measuring — survival, motor function, seizure count, quality of life. Ask: Is that what we care about for our child?
Sponsor & contact
Who is running it (university, company, government) and who to email or call for more information.
Words that actually matter
- Recruiting
- Accepting new participants. This is the word you want to see.
- Placebo-controlled
- Some participants receive inactive treatment for comparison. Ask how placebo assignment works and whether everyone eventually gets the real treatment.
- Double-blind
- Neither you nor the doctor knows which treatment your child is getting. Reduces bias; can be emotionally hard for families.
- Open-label
- Everyone knows what treatment is being given. More transparent; sometimes follows a blinded phase.
- Expanded access / Compassionate use
- Not a trial — a pathway to access an investigational treatment outside a study. Different rules, different listings.
- NCT number
- A unique ID (e.g. NCT01234567). Use it when talking to doctors so everyone means the same study.
USA vs EU — practical differences
Green flags & red flags
Green flags
- Run by a known hospital, university, or established company
- Clear contact person who responds to questions
- Informed consent process explained in plain language
- Your child's own specialist knows about the study and supports you exploring it
Red flags
- Pressure to enroll immediately without time to think
- Large upfront fees to participate
- Promises of a cure with no discussion of risks
- No IRB/ethics approval (US) or regulatory authorisation (EU)
- Discouraging you from talking to your current medical team
Questions to ask before enrolling
- Why is this trial a fit for my child's specific diagnosis and mutation?
- What are the known risks — and what happens if something goes wrong?
- Will my child receive placebo? For how long?
- How many visits, and where? Can we manage the travel?
- What costs are covered — and what comes out of our pocket?
- Can we leave the trial if it's not working or feels wrong?
- What happens after the trial ends — continued access, follow-up, or nothing?
What to do next
- Search for your child's condition + "recruiting" on the registry for your region.
- Save the NCT number or EU trial ID and email it to your specialist: "Is this worth exploring?"
- Read our gene therapy guide if the trial involves a genetic treatment.
- Email VENE if you want help thinking through a listing — we're not doctors, but we can help you organize your questions.